A 25-Minute Walk Could Add Seven Years to Life

Translate to Spanish or other 102 languages!

Sanjay Sharma, professor of inherited cardiac diseases in sports cardiology.
Sanjay Sharma, professor of inherited cardiac diseases in sports cardiology.

Mega Doctor News – 

- Advertisement -

Just 25 minutes of brisk walking a day could add to seven years to your life, heart experts have said.

Researchers said moderate exercise could decrease the risk of heart attack death among those in their fifties and sixties.

The new research, presented on Sunday at the European Society of Cardiology (ESC) congress suggests that regular exercise can delay the ageing process.

- Advertisement -

The German study put men and women aged between 30 and 60 on a daily program of exercise.

They were selected because until then they had not been regular exercisers. The study then tracked key markers of ageing in the blood. Within just six months, these showed changes in the body which help to repair the DNA.

Experts said just 25 minutes of brisk walking or slow jogging every day could buy extra years of health – and happiness.

Sanjay Sharma, professor of inherited cardiac diseases in sports cardiology at St George’s University Hospitals NHS Foundation Trust in London, said: “When you exercise moderately, you reduce your risk of dying from a heart attack when you’re in your 50s and 60s by 50 per cent. That’s a really big deal.” Everyone should try to build in such habits to their daily routine, he said.

- Advertisement -

“Exercise buys you three to seven additional years of life. It is an anti-depressant, it improves cognitive function and there is now evidence that it may retard the onset of dementia,” the cardiologist said.  MDN

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AMA Unveils New Initiative to Boost Nutrition Education Nationwide

The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

The Silent Toll of Substance Use on Today’s Young Adults

Mega Doctor News by University of Michigan Newswise - Young adults who heavily use substances...

New Study Identifies Hormone Linking Obesity to Pancreatic Cancer

Mega Doctor News by Yale School of Medicine Newswise — Obesity increases the body's need...
- Advertisement -